BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
State Street SPDR Dow Jones REIT ETF
RWR
$1.97B
| $924K | ﹤0.01% |
9,063
+16
| +0.2% | +$1.66K |
|
|
PMD
3902
DELISTED
Psychemedics Corporation
PMD
| $920K | ﹤0.01% |
100,503
-1,225
| -1% | -$11.3K |
|
|
CIH
3903
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $917K | ﹤0.01% |
+251,955
| New | +$883K |
|
3904
Forte Biosciences
FBRX
$1.57B
| $903K | ﹤0.01% |
4,521
+228
| +5% | +$51.7K |
|
3905
Veritone
VERI
$122M
| $900K | ﹤0.01% |
361,145
+155,325
| +75% | +$449K |
|
|
STRR
3906
Star Equity Holdings
STRR
$41.7M
| $897K | ﹤0.01% |
75,124
-91
| -0.1% | -$1.1K |
|
3907
Exicure
XCUR
$8.54M
| $896K | ﹤0.01% |
2,090
+1,008
| +93% | +$412K |
|
|
GRTX
3908
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $890K | ﹤0.01% |
+67,634
| New | +$825K |
|
|
CSS
3909
DELISTED
CSS Industries, Inc.
CSS
| $882K | ﹤0.01% |
200,070
-109
| -0.1% | -$491 |
|
3910
MakeMyTrip
MMYT
$5.64B
| $866K | ﹤0.01% |
37,802
-295
| -0.8% | -$7.13K |
|
3911
Tilray
TLRY
$622M
| $862K | ﹤0.01% |
5,031
+10
| +0.2% | +$2.07K |
|
3912
CB Financial Services
CBFV
$193M
| $854K | ﹤0.01% |
28,329
-6,140
| -18% | -$174K |
|
3913
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $854K | ﹤0.01% |
5,775
+27
| +0.5% | +$3.82K |
|
|
EMKR
3914
DELISTED
Emcore Corp
EMKR
| $853K | ﹤0.01% |
28,048
-68
| -0.2% | -$2.05K |
|
3915
Curis
CRIS
$7.83M
| $851K | ﹤0.01% |
1,252
-2
| -0.2% | -$1.45K |
|
3916
Tenax Therapeutics
TENX
$503M
| $845K | ﹤0.01% |
374
| – | – |
|
3917
Schwab US REIT ETF
SCHH
$11.4B
| $834K | ﹤0.01% |
36,282
-8,090
| -18% | -$188K |
|
3918
WhiteHorse Finance
WHF
$146M
| $826K | ﹤0.01% |
60,260
+2,762
| +5% | +$38.6K |
|
3919
Larimar Therapeutics
LRMR
$432M
| $823K | ﹤0.01% |
61,818
-30,308
| -33% | -$290K |
|
|
AINC
3920
DELISTED
Ashford Inc.
AINC
| $819K | ﹤0.01% |
34,666
+7,665
| +28% | +$183K |
|
3921
Clarivate
CLVT
$1.16B
| $817K | ﹤0.01% |
+48,651
| New | +$819K |
|
3922
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
| $813K | ﹤0.01% |
16,135
+4,567
| +39% | +$230K |
|
|
SHLO
3923
DELISTED
Shiloh Industries Inc
SHLO
| $811K | ﹤0.01% |
227,717
-301
| -0.1% | -$1.16K |
|
|
CLUB
3924
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $808K | ﹤0.01% |
472,489
+5,634
| +1% | +$9.76K |
|
3925
Tecnoglass Holdings Inc.
TGLS
$1.96B
| $805K | ﹤0.01% |
97,547
-7,002
| -7% | -$56.5K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.